Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MEP1B | Q16820 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.37 |
| ▸ | EYA2 | O00167 | 1/20 | 0.37 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | ACE | P12821 | 1/20 | 0.37 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | DRD1 | P21728 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12545554 | 0.98 | MEP1B (0.42) | ALDH1A1MEP1BTDP1LMNATSHR | |
| SCHEMBL5322399 | 0.93 | TDP1 (0.45) | TDP1LMNATSHREYA2APP | |
| SCHEMBL9405391 | 0.91 | CA1 (0.38) | ALDH1A1MEP1BTDP1LMNAPSMD14 | |
| SCHEMBL17354914 | 0.91 | PSMD14 (0.35) | ALDH1A1MEP1BTDP1LMNATSHR | |
| SCHEMBL14341631 | 0.88 | NR1D1 (0.40) | MEP1BHDAC6HDAC3CA1CA2 | |
| SCHEMBL13958014 | 0.84 | LTA4H (0.44) | TDP1AGTR2HDAC6HDAC3KDM4E | |
| SCHEMBL18460451 | 0.84 | KCNH2 (0.44) | TDP1LMNATSHREYA2APP | |
| SCHEMBL13958499 | 0.83 | TDP1 (0.40) | ALDH1A1MEP1BTDP1KDM4ECA1 | |
| SCHEMBL18493213 | 0.82 | ALDH1A1 (0.55) | ALDH1A1TDP1TSHRHDAC6HDAC3 | |
| SCHEMBL13958502 | 0.80 | NR3C1 (0.43) | ALDH1A1TDP1LMNATSHRPSMD14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12245591-B2 | Templated antimicrobial microgels and methods of making and using the same | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2025-03-11 | — | — | US | claimed |
| CN-119472194-A | Phenol-free positive photoresist stripping liquid and preparation method thereof | 浙江尚能实业股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| EP-2432588-B1 | POROUS POLYMERIC SEPARATION MATERIAL | BIOTAGE AB (SE) | 2017-01-18 | — | — | EP | claimed |
| US-9023770-B2 | Increasing fracture complexity in ultra-low permeable subterranean formation using degradable particulate | HALLIBURTON ENERGY SERVICES, INC. (US) | 2015-05-05 | — | — | US | claimed |
| EP-2670815-A1 | INCREASING FRACTURE COMPLEXITY IN ULTRA-LOW PERMEABLE SUBTERRANEAN FORMATION USING DEGRADABLE PARTICULATE | Halliburton Energy Services, Inc. (US) | 2013-12-11 | — | — | EP | claimed |
| WO-2012104582-A1 | INCREASING FRACTURE COMPLEXITY IN ULTRA-LOW PERMEABLE SUBTERRANEAN FORMATION USING DEGRADABLE PARTICULATE | HALLIBURTON ENERGY SERVICES INC. (US) | 2012-08-09 | — | — | WO | claimed |
| US-20120128842-A1 | POROUS POLYMERIC SEPARATION MATERIAL | BIOTAGE AB (SE) | 2012-05-24 | — | — | US | claimed |
| EP-2432588-A1 | POROUS POLYMERIC SEPARATION MATERIAL | Biotage AB (SE) | 2012-03-28 | — | — | EP | claimed |
| US-20110120712-A1 | INCREASING FRACTURE COMPLEXITY IN ULTRA-LOW PERMEABLE SUBTERRANEAN FORMATION USING DEGRADABLE PARTICULATE | HALLIBURTON ENERGY SERVICES, INC. (US) | 2011-05-26 | — | — | US | claimed |
| US-20110089317-A1 | Polarization Standards for Microscopy | UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORTH WORTH (US) | 2011-04-21 | — | — | US | claimed |
| US-7001963-B2 | Cobalt imprinted polymer composition for selective removal of cobalt, process for preparation thereof, and process for removal of cobalt | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-02-21 | — | — | US | claimed |
| WO-2005063835-A1 | COBALT IMPRINTED POLYMER COMPOSITION, PREPARATION AND USE THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2005-07-14 | — | — | WO | claimed |
| US-20050070677-A1 | Cobalt imprinted polymer composition for selective removal of cobalt, process for preparation thereof, and process for removal of cobalt | COUNCIL OF SCIENTIF AND INDUSTRIAL RESEARCH (IN) | 2005-03-31 | — | — | US | claimed |
| US-20050070676-A1 | Cobalt imprinted polymer composition for selective removal of cobalt, process for preparation thereof, and process for removal of cobalt | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-03-31 | — | — | US | claimed |
| EP-0873106-B1 | USE OF METALLOFLUOROCOMPLEXES FOR DENTAL COMPOSITIONS | MINNESOTA MINING & MFG (US) | 2003-05-02 | — | — | EP | claimed |
| US-6391286-B1 | CURABLE DENTAL COMPOSITION COMPRISING PREFORMED METAL COMPLEX AS FLUORIDE RELEASING MATERIAL | 3M INNOVATIVE PROPERTIES COMPANY | 2002-05-21 | — | — | US | claimed |
| US-6177513-B1 | Method for evaluating artificial receptors | TOSHIFUMI TAKEUCHI (JP) | 2001-01-23 | — | — | US | claimed |
| WO-1998008585-A1 | LEACHING OF METAL CHALCOGENIDE (SULFIDE-TYPE) MINERALS WITH OXIDIZING AND CHELATING AGENTS | GEOCHEM TECHNOLOGIES, INC. (US) | 1998-03-05 | — | — | WO | claimed |
| US-5310648-A | Polymer-metal chelate compound | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1994-05-10 | — | — | US | claimed |
| US-4904354-A | IMPROVED ADHESION | LEARONAL INC. (US) | 1990-02-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12245591-B2 | Templated antimicrobial microgels and methods of making and using the same | MGAM, CD14, CD68 | ALDH1A1 3189/4885MEP1B 1489/4885TDP1 4158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.